Literature DB >> 16214348

Anti-tumor and proapoptotic effect of novel synthetic benzophenone analogues in Ehrlich ascites tumor cells.

B T Prabhakar1, Shaukath Ara Khanum, K Jayashree, Bharathi P Salimath, S Shashikanth.   

Abstract

A series of substituted benzophenone analogues, (2-aroyl-4-methylphenoxy)acetamides 4a-e, have been synthesized via three-step synthesis sequence beginning with the 2-hydroxybenzophenones 1a-e in excellent yield. 1a-e on reaction with ethyl chloroacetate afford ethyl (2-aroyl-4-methylphenoxy)acetates 2a-e which on alkaline hydrolysis afforded (2-aroyl-4-methylphenoxy)ethanoic acid 3a-e. Compounds 3a-e on condensation with p-chloroaniline furnished benzophenone analogues 4a-e. In the present report, we investigated the anti-tumor and proapoptotic effect of benzophenones in Ehrlich ascites tumor (EAT) cells. Treatment of benzophenones in vivo resulted in inhibition of proliferation of EAT cells and ascites formation. Further, we demonstrate that the induction of apoptosis in EAT cells is mediated through activation of caspase-3. These results suggest a further possible clinical application of these synthetic compounds as potent anti-tumor and proapoptotic compounds.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214348     DOI: 10.1016/j.bmc.2005.08.039

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  11 in total

1.  Radiation-induced cell cycle arrests in Ehrlich ascites carcinoma cells in vivo.

Authors:  S V Tokalov; A S Iagunov
Journal:  Radiat Environ Biophys       Date:  2011-01-23       Impact factor: 1.925

2.  Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases.

Authors:  Dima A Sabbah; Neka A Simms; Michael G Brattain; Jonathan L Vennerstrom; Haizhen Zhong
Journal:  Bioorg Med Chem Lett       Date:  2011-12-13       Impact factor: 2.823

Review 3.  Benzophenone: a ubiquitous scaffold in medicinal chemistry.

Authors:  Khemchand Surana; Bharatkumar Chaudhary; Monika Diwaker; Satyasheel Sharma
Journal:  Medchemcomm       Date:  2018-08-23       Impact factor: 3.597

4.  Antiangiogenic effect of 2-benzoyl-phenoxy acetamide in EAT cell is mediated by HIF-1alpha and down regulation of VEGF of in-vivo.

Authors:  B T Prabhakar; Shaukath Ara Khanum; S Shashikanth; Bharathi P Salimath
Journal:  Invest New Drugs       Date:  2006-11       Impact factor: 3.850

5.  Anti-neoplastic pharmacophore benzophenone-1 coumarin (BP-1C) targets JAK2 to induce apoptosis in lung cancer.

Authors:  Ankith Sherapura; Vikas H Malojirao; Prabhu Thirusangu; B S Sharath; Shivananda Kandagalla; V Vigneshwaran; Jurica Novak; Lakshmi Ranganatha; Y L Ramachandra; Shrinath M Baliga; Shaukath Ara Khanum; B T Prabhakar
Journal:  Apoptosis       Date:  2021-11-27       Impact factor: 4.677

6.  Marsdenia tenacissima extract suppresses tumor growth and angiogenesis in A20 mouse lymphoma.

Authors:  Xingbin Dai; Yanhua Ji; Pengjun Jiang; Xuemei Sun
Journal:  Oncol Lett       Date:  2017-03-08       Impact factor: 2.967

7.  Synthesis and Bioactivity Evaluation of Novel 2-Salicyloylbenzofurans as Antibacterial Agents.

Authors:  Phuong-Thuy T Phan; Thu-Trang T Nguyen; Hong-Nhung T Nguyen; Bao-Khanh N Le; Thao T Vu; Dong C Tran; Tuan-Anh N Pham
Journal:  Molecules       Date:  2017-04-25       Impact factor: 4.411

8.  The critical role of novel benzophenone analogs on tumor growth inhibition targeting angiogenesis and apoptosis.

Authors:  Yasser Hussein Eissa Mohammed; Shaukath Ara Khanum
Journal:  Medchemcomm       Date:  2018-02-15       Impact factor: 3.597

9.  Ethyl 2-[4-(2-chloro-benzo-yl)-2,6-di-methyl-phen-oxy]ethano-ate.

Authors:  T Prashanth; V Lakshmi Ranganatha; M K Usha; Shaukath Ara Khanum; D Revannasiddaiah; Sumati Anthal; Rajni Kant; Vivek K Gupta
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-07-14

10.  Gracilaria edulis extract induces apoptosis and inhibits tumor in Ehrlich ascites tumor cells in vivo.

Authors:  Satyajit Patra; Meenakshi Sundaram Muthuraman
Journal:  BMC Complement Altern Med       Date:  2013-11-25       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.